Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Date of authorisation: 25/10/2012, Revision: 38, Status: Authorised
MedDRA important medical event terms list - version 29.0
EMA’s biennial report on stakeholder engagement activities 2024-2025
Plant testing strategy in the risk assessment for veterinary medicinal products - Scientific guideline
Guidance and template on the risk management plan (RMP) for novel therapy veterinary medicinal products - Scientific guideline
Chemistry of active substances (chemistry of new active substances) - Scientific guideline
Innovation Task Force (ITF) briefing meeting report
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 April 2026, 09:30 (CEST) to 24 April 2026, 11:30 (CEST)
Introductory cover note to the list of European Union reference dates and frequency of submission of periodic safety update reports
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - March 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 March 2026, 10:00 (CET) to 23 March 2026, 12:00 (CET)